The Medical Technology Research Group (MTRG) is a research unit within the London School of Economics and Political Science (LSE) concentrating on interdisciplinary and comparative policy research on medical technologies. The group aims to produce high quality research and to provide education, training, policy support and advice to key stakeholders, including governments and international organisations. Central to the activities of the group and its members is a focus on policy analysis and policy evaluation.
The groups conducts research in four main areas: the economics of medical technologies, sustainability of health care financing, access to medical technologies in developing, transition and emerging economies and on disease management and the effectiveness of policies on medical technology.
The Group administers, the Programme on Pharmaceutical Policy Issues (PPPI), the Programme on Medical Devices, conducts research under the auspices of and participates in the European Medicines Information Network (EMI-net) and the Network on Rare Diseases (BURQOL-RD), the Optimal Expenditure Network, and is a member of the European Health technology Institute for Socio-Economic Research (EHTI). It regularly works with the World Health Organization on projects related to pharmaceutical policy. MTRG also leads a consortium to advance and strengthen the methodological tools and practices relating to the application and implementation of health technology assessment (Advance-HTA) funded by European Commission under DG-Research 7th framework programme. It also coordinates The Patient Research Network, an initiative between academia, and individual health care stakeholders, including patients, practitioners and hospital managers to promote the diffusion of knowledge to stakeholder groups of health care issues and policies.